| 000 | 01550 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514214626.0 | ||
| 264 | 0 | _c20050311 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0300-483X | ||
| 024 | 7 |
_a10.1016/j.tox.2004.10.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChander, Vikas | |
| 245 | 0 | 0 |
_aEffect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide. _h[electronic resource] |
| 260 |
_bToxicology _cFeb 2005 |
||
| 300 |
_a463-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrinking |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aKidney Diseases _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMolsidomine _xadministration & dosage |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xadministration & dosage |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aWater Supply |
| 700 | 1 | _aChopra, Kanwaljit | |
| 773 | 0 |
_tToxicology _gvol. 207 _gno. 3 _gp. 463-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tox.2004.10.018 _zAvailable from publisher's website |
| 999 |
_c15342947 _d15342947 |
||